RIPK3 and leukemia: However, the downregulation of another key member, RIPK3, is associated with low survival in acute myeloid leukemia, suggesting its antitumor effects through facilitating RIPK3-MLKL-mediated necroptosis and the differentiation of leukemia-initiating cells [12].